PepDiana
Back to Evidence
Primary experimental recordNegative / threshold

PMC12891685::ACT035937

NY-ESO-1

Evidence text

Paper-level observation

The IFNγ/GrB-ELISPOT results show in principle that LAG-3 has no effect either alone or in combination with anti-PD-1 (Fig. 4A).
textConfidence: medium

Assay observation

Activity
Immunomodulatory
Subtype
Antibacterial
Measure
fold_change
Comparator
=
Raw observation
no effect
Normalized measurement
=3
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Homo sapiens
Assay method
Not reported by source
Sequence
SLLMWITQC
Standardization
ready simple

Source publication

Immune checkpoint inhibition increases antigen-specific T cell response in head and neck cancer

Scientific Reports · 2026

DOI 10.1038/s41598-026-38740-z PMC12891685
Parent mention

Related peptide identities

PEPDIA-PLP-002699

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.